Harrow, Inc. (HROW)
50.15
-0.05
(-0.10%)
USD |
NASDAQ |
Dec 11, 13:47
Harrow Price: 50.15 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.64 |
| Skye Bioscience, Inc. | 1.175 |
| Theravance Biopharma, Inc. | 17.48 |
| FibroGen, Inc. | 9.01 |
| Myomo, Inc. | 1.075 |
Price Related Metrics
| PS Ratio | 7.489 |
| Price to Book Value | 39.51 |
| Earnings Yield | -0.30% |
| Market Cap | 1.857B |
| Operating PE Ratio | 66.70 |